Moneycontrol PRO
Live Now |Super25 3.0- India’s Largest Online Stock Traders Conference brought to you by Moneycontrol Pro & Espresso
you are here: HomeNewscoronavirus

India reports over 2.35 lakh COVID-19 cases, 871 fatalities

The active cases decreased by 1,01,278 to reach 20,04,333 — 4.91 percent of the total infections — while the country’s recovery rate stands at 93.89 percent, the ministry said.

January 29, 2022 / 09:57 AM IST
(Representative Image: AP)

(Representative Image: AP)

With 2,35,532 people testing positive for the COVID-19 infection in a day, India’s total tally of cases increased to over 4.08 crore, according to the Union Health Ministry data updated on Saturday.

The death toll has climbed to 4,93,198 with 871 fatalities reported during the 24-hour period, the data updated at 8 am showed.

The active cases decreased by 1,01,278 to reach 20,04,333 — 4.91 percent of the total infections — while the country’s recovery rate stands at 93.89 percent, the ministry said.

The daily positivity rate was recorded at 13.39 percent, while the weekly positivity rate was 16.89 per cent, according to the health ministry.

The number of people who have recuperated from the disease surged to 3,83,60,710, while the case fatality rate was recorded at 1.21 per cent, the ministry said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

After the Saturday update, the total number of infections stands at 4,08,58,241, it said. Meanwhile, the cumulative number of anti-Covid vaccine doses administered in the country so far has crossed 165.04 crore.

India’s surpassed the one-crore mark in the number of cases on December 19, 2020. It crossed the grim milestone of two crore on May 4 and three crore on June 23.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

PTI
first published: Jan 29, 2022 09:57 am
Sections
ISO 27001 - BSI Assurance Mark